References
- Young LS. Antimicrobial prophylaxis against infection in neutropenic patients (Editorial). J Infect Dis 1983; 147: 611–614.
- Henry SA. Symposium on infectious complications of neoplastic disease (Part II ). Chemoprophylaxis of bacterial infections in granulocytopenic patients. Am J Med 1984; 76: 645–651
- Young LS. Antimicrobial prophylaxis in neutropenic host: lessons of the past and perspective for the future. Eur J Clin Microbiol Infect Dis 1988; 7: 93–97.
- Dekker AW, Rozemberg-Arska M, Verhoef J. Infection prophylaxis in acute leukaemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin. Ann Intern Med 1987; 106: 7–12.
- Arning M, Wolf HH, Aul C, Heyll A, Scharf RE, Schneider W. Infection prophylaxis in neutropenic patients with acute leukaemia - a randomized, comparative study with ofloxacin, ciprofloxacin and cotrimoxazole/colistin. J Antimi-crob Chemother 1990; 26: (suppl D): 137–142.
- Bergan T, Thorsteinsson SB, Solberg R, Bjornskau L, Kolstad IM, Johnsen S. Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses. Am J Med 1987; 82 (suppl 4A): 97–102.
- Wise R, Donovan IA. Tissue penetration and metabolism of ciprofloxacin. Am J Med 1987; 82 (suppl 4A): 103–107.
- Muytjens HL, Van der Rosvan De Repe J, Van Veldhuizen G. Comparative activities of ciprofloxacin (Bay 09867), norfloxacin, pipemidic acid and nalidixic acid. Antimicrob Agents Chemother 1983; 24: 302–304.
- Bergan T, Delin C, Johansen S, Kolstad IM, Nord CE, Thorsteinsson SB. Pharmacokinetics of ciprofloxacin and effect of repeated dosage on salivary and fecal microflora. Antimicrob Agents Chemother 1986; 29: 298–302d.
- Dennig H, Fulle H, Hellriegel KP. Chemoprophylaxis of bacterial infections in granulocytopenic patients with ciprofloxacin. Onkologie 1987; 10: 57–58.
- Warren RE, Wimperis JZ, Baglin TP, Constantine CE, Marcus R. Prevention of infection by ciprofloxacin in neutropenia. J Antimicrob Chemother 1990; 26: 109–123.
- De Pauw BE, Donnelly JP, De Witte T, Novakova' IRO, Schattenberg A. Options and limitations of long-term oral ciprofloxacin as antibacterial prophylaxis in allogeneic bone marrow transplant recipients. Bone Marrow Transplant 1990; 5: 179–182.
- Gimema Infection program. Prevention of bacterial infection in neutropenic patients with hematologic malignancies. Ann Intern Med 1991; 115: 7–12
- Ratzan KR. The role of surface factors in pathogenesis of infection. In: Weinstein L, Fields BN, eds. Seminars in Infectious Diseases New York: Stratton Intercontinental, 1979; 145–172.
- Cohen J, Worsley AM, Goldman JM, Donnelly JP, Catowsky D, Galton DAG. Septicemia caused by viridans streptococci in neutropenic patients with acute leukaemia. Lancet 1983; ii: 1452–1454.
- Menichetti F, Felicini R, Bucaneve G, et al. Norfloxacin prophylaxis for neutropenic patients undergoing bone marrow transplantation. Bone Marrow Transplant 1989; 4: 489–492.